Vendor, Emeryville, CA
Gritstone Bio, Inc.
UEI WPNLFZK8MA87, CAGE 9L4G1
1 award and $0 obligated between March 11, 2024 and March 12, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50123C00062Definitive Contract, March 11, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Developing a Next-Generation Vaccine That Drives (A) More Durable and Broad Anti-Spike Neutralizing Antibodies (Nabs) Against Variants of CoNAICS 541714, PSC AN14 | $0 |
- Places of performance
- Massachusetts
- Product and service codes
- AN14 Health R&D Services; Health Care Services; R&D Administrative Expenses
- Transactions
- 3 across 1 awards